Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AMPA receptor (AMPAR) is a ligand-gated ion channel that mediates fast excitatory neurotransmission in the central nervous system (CNS). It is a tetrameric complex composed of GluA1, GluA2, GluA3, and GluA4 subunits. Upon binding glutamate, the channel opens, allowing Na⁺ (and sometimes Ca²⁺) influx, leading to depolarization. AMPARs are crucial for synaptic plasticity, learning, and memory, and are implicated in neurological conditions like epilepsy and autoimmune encephalitis.
Ligand-gated ion channel activation leading to Na⁺ and Ca²⁺ influx and neuronal depolarization
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid receptor (None).